Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Operating costs and expenses:    
Research and development $ (1,221,144) $ (429,281)
General and administrative (1,634,533) (1,422,366)
Loss from operations (2,855,677) (1,851,647)
Other non-operating income (expense):    
Change in fair value of derviative liability 0 136,014
Loss on issuance of hybrid debt instrument 0 (1,584,218)
Other expense (9,356) (26,414)
Interest income 0 14
Interest expense (588) (245,384)
Total other non-operating expense (9,944) (1,719,988)
Net loss $ (2,865,621) $ (3,571,635)
Basic and diluted loss per share $ (.34) $ (.78)
Weighted-average shares of common stock outstanding, basic and diluted 8,518,830 4,591,364